| |
|
|
| Name: |
VR Adviser LLC |
| City: |
New York |
| State: |
NY |
| Zip: |
10018 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
44 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
APGE |
Apogee Therapeutics, Inc. |
1 |
- |
$47.87 |
$564,381,000 |
8,493,321 |
26.85% |
327,078,000 |
0 |
17.687 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
2 |
- |
$0.00 |
$140,184,000 |
4,400,000 |
6.67% |
70,813,000 |
975,969 |
8.918 |
N/A |
|
|
OCUL |
Ocular Therapeutix, Inc |
3 |
- |
$0.00 |
$116,138,000 |
12,762,462 |
5.52% |
81,458,000 |
4,986,702 |
11.579 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
4 |
- |
$0.60 |
$82,376,000 |
2,171,782 |
3.92% |
31,315,000 |
-200,932 |
3.55 |
N/A |
|
|
MRUS |
Merus Nv |
5 |
- |
$43.40 |
$80,613,000 |
1,790,214 |
3.83% |
21,537,000 |
-358,000 |
3.101 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
6 |
- |
$0.00 |
$78,472,000 |
3,395,606 |
3.73% |
-16,775,000 |
0 |
8.199 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
7 |
- |
$11.69 |
$74,122,000 |
6,249,731 |
3.53% |
23,986,000 |
2,157,000 |
16.44 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
8 |
- |
$0.00 |
$70,823,000 |
4,026,331 |
3.37% |
29,927,000 |
1,071,429 |
9.77 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
9 |
- |
$12.70 |
$67,986,000 |
3,882,671 |
3.23% |
-16,578,000 |
48 |
6.191 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
10 |
- |
$0.70 |
$62,831,000 |
2,094,373 |
2.99% |
53,183,000 |
1,166,667 |
14.132 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
11 |
- |
$31.53 |
$61,717,000 |
2,173,913 |
2.94% |
32,804,000 |
0 |
2.68 |
N/A |
|
|
APLT |
Applied Therapeutics Inc. |
12 |
- |
$0.00 |
$61,710,000 |
9,075,000 |
2.94% |
40,772,000 |
2,825,000 |
11.751 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
13 |
- |
$0.00 |
$60,425,000 |
4,394,527 |
2.87% |
38,084,000 |
1,966,142 |
6.554 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
14 |
- |
$9.11 |
$50,792,000 |
3,608,645 |
2.42% |
26,018,000 |
382,839 |
6.601 |
N/A |
|
|
MRSN |
Mersana Therapeutics, Inc. |
15 |
- |
$2.57 |
$50,749,000 |
11,328,000 |
2.41% |
24,468,000 |
0 |
9.395 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
16 |
New |
$13.22 |
$43,491,000 |
2,565,841 |
2.07% |
43,491,000 |
2,565,841 |
11.06 |
N/A |
|
|
PRAX |
Praxis Precision Medicines,... |
17 |
- |
$0.00 |
$43,088,000 |
706,126 |
2.05% |
35,209,000 |
352,500 |
1.348 |
N/A |
|
|
HLVX |
Hillevax, Inc. |
18 |
- |
$14.14 |
$34,507,000 |
2,075,000 |
1.64% |
1,203,000 |
0 |
4.284 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
19 |
- |
$8.03 |
$34,468,000 |
5,129,167 |
1.64% |
6,925,000 |
445,000 |
5.414 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
20 |
New |
$0.00 |
$33,164,000 |
1,818,182 |
1.58% |
33,164,000 |
1,818,182 |
1.971 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
21 |
- |
$0.00 |
$26,681,000 |
1,563,952 |
1.27% |
-31,521,000 |
-1,000,000 |
3.042 |
N/A |
|
|
ARVN |
Arvinas Holding Company, Llc |
22 |
- |
$35.95 |
$25,915,000 |
627,788 |
1.23% |
75,000 |
0 |
0.913 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
23 |
- |
$0.00 |
$25,830,000 |
9,000,000 |
1.23% |
7,399,000 |
-1,412,872 |
4.814 |
N/A |
|
|
AQST |
Aquestive Therapeutics, Inc. |
24 |
New |
$3.15 |
$23,667,000 |
5,555,555 |
1.13% |
23,667,000 |
5,555,555 |
16.525 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
25 |
- |
$5.93 |
$22,370,000 |
3,410,058 |
1.06% |
-6,816,000 |
-1,087,059 |
5.256 |
N/A |
|
|
ADVM |
Adverum Biotechnologies, Inc |
26 |
- |
$7.90 |
$22,008,000 |
1,556,419 |
1.05% |
18,133,000 |
-3,591,128 |
1.541 |
N/A |
|
|
CELC |
Celcuity Inc. |
27 |
- |
$15.99 |
$20,952,000 |
970,000 |
1% |
-6,520,000 |
-915,538 |
4.476 |
N/A |
|
|
ABVX |
Abivax S.A |
28 |
- |
$14.30 |
$19,245,000 |
1,345,780 |
0.92% |
8,560,000 |
347,210 |
2.171 |
N/A |
|
|
IMTX |
Immatics N.V |
29 |
New |
$10.34 |
$18,393,000 |
1,750,000 |
0.87% |
18,393,000 |
1,750,000 |
2.782 |
N/A |
|
|
LYRA |
Lyra Therapeutics, Inc. |
30 |
- |
$0.00 |
$16,023,000 |
2,576,093 |
0.76% |
2,527,000 |
500 |
4.901 |
N/A |
|
|
CGON |
CG Oncology, Inc |
31 |
New |
$30.81 |
$15,365,000 |
350,000 |
0.73% |
15,365,000 |
350,000 |
0.53 |
N/A |
|
|
IPSC |
Century Therapeutics, Inc. |
32 |
New |
$0.00 |
$14,233,000 |
3,405,133 |
0.68% |
14,233,000 |
3,405,133 |
6.211 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
33 |
- |
$0.00 |
$11,808,000 |
3,422,675 |
0.56% |
7,222,000 |
278 |
5.712 |
N/A |
|
|
TNYA |
Tenaya Therapeutics, Inc. |
34 |
New |
$0.00 |
$8,136,000 |
1,555,556 |
0.39% |
8,136,000 |
1,555,556 |
2.431 |
N/A |
|
|
MLYS |
Mineralys Therapeutics, Inc. |
35 |
New |
$0.00 |
$7,172,000 |
555,554 |
0.34% |
7,172,000 |
555,554 |
1.36 |
N/A |
|
|
SLRN |
Acelyrin, Inc. |
36 |
- |
$4.52 |
$6,326,000 |
937,113 |
0.3% |
-665,000 |
0 |
0.964 |
N/A |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
37 |
- |
$0.44 |
$5,168,000 |
250,000 |
0.25% |
-610,000 |
0 |
0.174 |
Biotechnology |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
38 |
- |
$0.00 |
$872,000 |
77,042 |
0.04% |
-209,000 |
0 |
0.14 |
N/A |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
41 |
Closed |
$37.84 |
$0 |
0 |
0% |
-22,800,000 |
-495,983 |
0 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
44 |
Closed |
$0.00 |
$0 |
0 |
0% |
-7,646,000 |
-1,318,327 |
0 |
N/A |
|
|
MIST |
Milestone Pharmaceuticals Inc. |
40 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,545,000 |
-925,048 |
0 |
N/A |
|
|
AMAM |
Ambrx Biopharma Adr Represe... |
43 |
Closed |
$0.00 |
$0 |
0 |
0% |
-29,477,000 |
-2,070,000 |
0 |
N/A |
|
|
RYZB |
Rayzebio, Inc. |
39 |
Closed |
$62.49 |
$0 |
0 |
0% |
-250,574,000 |
-4,030,471 |
0 |
N/A |
|
|
SVRA |
Savara Inc |
42 |
Closed |
$4.33 |
$0 |
0 |
0% |
-16,450,000 |
-3,500,000 |
0 |
Biotechnology |
|
